Home / Denmark / Carlsberg A/S
Carlsberg A/S
Short position disclosed on May 7, 2026.
1.90% of the capital sold short
3 disclosing funds
106 disclosures on record
DK0010181759 ISIN code
Evolution of the disclosed total
0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
December 3, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Ilex Capital Partners (UK) LLP | 0.80% | new | May 7, 2026 | |
| AQR Capital Management, LLC | 0.60% | new | April 10, 2026 | |
| Kintbury Capital LLP | 0.50% | new | March 23, 2026 |
On the other side: the funds that hold Carlsberg A/S Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| January 13, 2015 | Marshall Wace LLP | 0.60% | January 13, 2015 |
| January 12, 2015 | Odey Asset Management LLP | 0.72% | January 12, 2015 |
| December 17, 2014 | Marshall Wace LLP | 0.57% | December 17, 2014 |
| December 17, 2014 | Odey Asset Management LLP | 0.51% | December 17, 2014 |
| December 8, 2014 | Marshall Wace LLP | 0.61% | December 8, 2014 |
| December 3, 2014 | Marshall Wace LLP | 0.51% | December 3, 2014 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Carlsberg A/S, source Finanstilsynet, data as at May 7, 2026, https://www.quivad.com/action/carlsberg-a-s?page=3